Heron Therapeutics, Inc. (HRTX)
Oxford Ledge is still expanding full research coverage of HRTX. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
Biotechnology company commercializing acute care and oncology products focused on pain management and nausea prevention.
SEC filings
- 8-K Delisting / transfer of listing; Financial statements and exhibits 2026-06-25
- 8-K Shareholder vote results 2026-06-16
- 8-K Other material event; Financial statements and exhibits 2026-06-02
- 10-Q Quarterly financial report (unaudited) 2026-05-11
- 8-K Results of operations / financial condition; Financial statements and exhibits 2026-05-11
Source: SEC EDGAR.
Insider activity
5 recent insider (SEC Form 4) filings on record for HRTX. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open HRTX in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.